Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer

Authors:

Abstract
This study was designed to clarify whether preoperative tumor size is an independent prognostic factor (IPF) for patients with Borrmann type III gastric cancer. The study group comprised 350 patients with Borrmann type III gastric cancer. We performed a log-rank plot analysis to establish the threshold value of preoperative tumor size for the prediction of overall survival (OS). Factors with P Peritoneal lavage cytology (CY) was the strongest IPF for patients with Borrmann type III gastric cancer (P P = 0.007) and preoperative tumor size (P = 0.018) were significant IPFs in the CY0 patients. Patients with a preoperative tumor size of 80 %. Preoperative tumor size is an IPF for patients with Borrmann type III gastric cancer and CY0. Thus, preoperative tumor size may be a useful factor for deciding on whether neoadjuvant chemotherapy is indicated.

This publication has 25 references indexed in Scilit: